1. Lin L, Li Z, Yan L, Liu Y, Yang H, Li H. Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019. J Hematol Oncol 2021;14:197.

2. Martos-Benítez FD, Soler-Morejón CD, Lara-Ponce KX, et al. Critically ill patients with cancer: a clinical perspective. World J Clin Oncol 2020;11:809–835.

3. Zampieri FG, Romano TG, Salluh JIF, et al. Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study. Intensive Care Med 2021;47:170–179.

4. Na SJ, Ha TS, Koh Y, et al. Characteristics and clinical outcomes of critically ill cancer patients admitted to Korean intensive care units. Acute Crit Care 2018;33:121–129.

5. Vigneron C, Charpentier J, Valade S, et al. Patterns of ICU admissions and outcomes in patients with solid malignancies over the revolution of cancer treatment. Ann Intensive Care 2021;11:182.

6. Koutsoukou A. Admission of critically ill patients with cancer to the ICU: many uncertainties remain. ESMO Open 2017;2:e000105.

7. Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A. Intensive care, survival, and expense of treating critically ill cancer patients. JAMA 1993;269:783–786.

8. van der Zee EN, Termorshuizen F, Benoit DD, et al. One-year mortality of cancer patients with an unplanned ICU admission: a cohort analysis between 2008 and 2017 in the Netherlands. J Intensive Care Med 2022;37:1165–1173.

9. Darmon M, Bourmaud A, Georges Q, et al. Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med 2019;45:977–987.

10. Ostermann M, Ferrando-Vivas P, Gore C, Power S, Harrison D. Characteristics and outcome of cancer patients admitted to the ICU in England, Wales, and Northern Ireland and national trends between 1997 and 2013. Crit Care Med 2017;45:1668–1676.

11. Wigmore T, Farquhar-Smith P. Outcomes for critically ill cancer patients in the ICU: current trends and prediction. Int Anesthesiol Clin 2016;54:e62–e75.

12. Nassar AP Jr, Dettino ALA, Amendola CP, Dos Santos RA, Forte DN, Caruso P. Oncologists’ and intensivists’ attitudes toward the care of critically ill patients with cancer. J Intensive Care Med 2019;34:811–817.

13. Qian J, Qin R, Hong L, et al. Characteristics and clinical outcomes of patients with lung cancer requiring ICU admission: a retrospective analysis based on the MIMIC-III database. Emerg Cancer Care 2023;2:1.

14. Chi SA, Yu H, Choi YL, et al. Trends in survival rates of non-small cell lung cancer with use of molecular testing and targeted therapy in Korea, 2010–2020. JAMA Netw Open 2023;6:e232002.

15. Toffart AC, Meert AP, Wallet F, et al. ICU admission for solid cancer patients treated with immune checkpoint inhibitors. Ann Intensive Care 2023;13:29.

16. Hong Y, Hong JY, Park J. Differences in ICU outcomes according to the type of anticancer drug in lung cancer patients. Front Med (Lausanne) 2022;9:824266.

17. Kemoun G, Weiss E, El Houari L, et al. Clinical features and outcomes of patients with pancreatic cancer requiring unplanned medical ICU admission: a retrospective multicenter study. Dig Liver Dis 2024;56:514–521.

18. Puxty K, McLoone P, Quasim T, Sloan B, Kinsella J, Morrison DS. Characteristics and outcomes of surgical patients with solid cancers admitted to the intensive care unit. JAMA Surg 2018;153:834–840.

19. Borcoman E, Dupont A, Mariotte E, et al. One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: a retrospective study. J Crit Care 2020;57:36–41.